Joseph Robert Volpicelli MD Ph.D.
Addiction
Executive Director Institute of Addiction Medicine
Join to View Full Profile
1000 Germantown PikeSte H2Plymouth Meeting, PA 19462
Phone+1 484-351-8031
Fax+1 484-351-8073
Dr. Volpicelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Pennsylvania Health SystemResidency, Psychiatry, 1982 - 1985
- St Luke's University HospitalInternship, Transitional Year, 1981 - 1982
- Perelman School of Medicine at the University of PennsylvaniaClass of 1981
Certifications & Licensure
- PA State Medical License 1982 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence Start of enrollment: 2007 Mar 01
- OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Start of enrollment: 2021 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- 8 citationsRethinking Unhealthy Alcohol Use in the United States: A Structured Review.Joseph R Volpicelli, Percy Menzies
Substance Abuse. 2022-01-01 - 23 citationsHeterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes.Charles Ruetsch, Joseph Tkacz, Vijay R Nadipelli, Brenna L. Brady, Naoko A Ronquest
The American Journal of Managed Care. 2017-06-01 - 64 citationsRelationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent Patients.Joseph Tkacz, Joseph R. Volpicelli, Hyong Un, Charles Ruetsch
Journal of Substance Abuse Treatment. 2014-04-01
Other
- Ambulatory alcohol detoxificationVolpicelli JR, Teitelbaum SA
http://www.uptodate.com/contents/ambulatory-alcohol-detoxification
UpToDate, Wolters Kluwer Health - 2013-03-12
Press Mentions
- Opioid Addiction: Overdose Risk Increases After Pain Relievers Are DiscontinuedDecember 1st, 2022
- In-Depth: Fighting the Deadly Growth of Opioid Overdoses During COVID-19August 31st, 2021
- Alkermes Launches New Disease State Website to Offer Education About Alcohol DependenceApril 29th, 2021
- Join now to see all
Grant Support
- Naltrexone Treatment Of Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism1992–2002
- Innovative Approaches For Cocaine PharmacotherapyNational Institute On Drug Abuse1999
- Rehabilitation For Cocaine Dependent New MothersNational Institute On Drug Abuse1996–1998
- Naltrexone Treatment Of Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism1989–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
